Gut Microbiota Changes in Irritable Bowel Syndrome
Author Information
Author(s): Li Xiaxi, Li Xiaoling, Xiao Haowei, Xu Jiaying, He Jianquan, Xiao Chuanxing, Zhang Bangzhou, Cao Man, Hong Wenxin
Primary Institution: Southern Medical University, Shenzhen Hospital, China
Hypothesis
The gut microbiota composition and diversity differ significantly between patients with irritable bowel syndrome (IBS) and healthy controls.
Conclusion
The study identified significant alterations in gut microbiota diversity and composition in IBS patients, suggesting potential biomarkers for diagnosis and treatment.
Supporting Evidence
- Significantly lower alpha-diversity indexes were observed in IBS patients.
- Twenty-six bacterial genera and twelve predicted pathways were identified with significant odds ratios for IBS patients.
- Ruminococcaceae and Christensenellaceae were negatively correlated with vitamin B6 metabolism in IBS patients.
Takeaway
This study looked at poop samples from people with and without tummy troubles to see how their gut bacteria are different. They found that the bacteria in people with tummy troubles are not as varied.
Methodology
The study performed a meta-analysis of 1167 fecal samples using 16S rRNA gene sequencing to assess gut microbiota diversity and composition.
Potential Biases
Potential sampling biases due to the variability in study populations and recruitment criteria.
Limitations
The study relied on publicly available data, which may lack detailed clinical information, and only utilized 16S data, limiting the ability to classify at a non-genus level.
Participant Demographics
623 IBS patients and 544 healthy controls from various studies.
Statistical Information
P-Value
0.001
Confidence Interval
Not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website